Community Financial (NASDAQ:TCFC) reported quarterly earnings of $1.34 per share. This is a 19.64 percent increase over earnings of $1.12 per share from the same period last year.
Safety Shot, Inc. (NASDAQ:SHOT) it has come to our attention that there are several disclosed short sellers publishing malicious defamatory, inaccurate articles about Safety Shot and its management in a willful attempt
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) today announced the Company's Phase 2 clinical trial of ATH434 for the treatment of patients with Multiple System Atrophy (MSA) is now open for enrollment at Vanderbilt University Medical Center in Nashville, Tennessee.
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 15 years by 19.74% on an annualized basis producing an average annual return of 26.98%. Currently, Regeneron Pharmaceuticals has a market capitalization of $63.16 billion.